Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Pulmonx Corporation is a medical technology company specializing in minimally invasive treatments for severe emphysema, a form of COPD. Its core products include the Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, and LungTraX Platform, used to improve lung function and quality of life. The company serves global markets, offering solutions that are safe, effective, and supported by extensive clinical data and regulatory approvals.
This description was generated via AI from an annual report. Updated about 1 year ago.